Literature DB >> 8612127

IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels.

Y Tagaya1, R N Bamford, A P DeFilippis, T A Waldmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8612127     DOI： 10.1016/s1074-7613(00)80246-0

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


× No keyword cloud information.
  100 in total

Review 1.  Future prospects for anti-cytokine treatment.

Authors:  M Feldmann; J Miotla; E Paleolog; R Williams; A M Malfait; P Taylor; F M Brennan; R N Maini
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  IL-15-induced conversion of monocytes to mature dendritic cells.

Authors:  K U Saikh; A S Khan; T Kissner; R G Ulrich
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  Production and distribution of interleukin 15 and its receptors (IL-15Ralpha and IL-R2beta) in the implant interface tissues obtained during revision of failed total joint replacement.

Authors:  S Saeed; P A Revell
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

4.  Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.

Authors:  SangKon Oh; Jay A Berzofsky; Donald S Burke; Thomas A Waldmann; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

5.  HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.

Authors:  Maria A De Francesco; Manuela Baronio; Simona Fiorentini; Costantino Signorini; Carlo Bonfanti; Claudio Poiesi; Mikulas Popovic; Manuela Grassi; Emirena Garrafa; Luisa Bozzo; George K Lewis; Stefano Licenziati; Robert C Gallo; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-08       Impact factor: 11.205

6.  Bench-to-bedside translation of interleukin-15 for immunotherapy: principles and challenges.

Authors:  Chalet Tan; Thomas A Waldmann
Journal:  Expert Opin Drug Deliv       Date:  2020-05-19       Impact factor: 6.648

7.  Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.

Authors:  E Liu; Y Tong; G Dotti; H Shaim; B Savoldo; M Mukherjee; J Orange; X Wan; X Lu; A Reynolds; M Gagea; P Banerjee; R Cai; M H Bdaiwi; R Basar; M Muftuoglu; L Li; D Marin; W Wierda; M Keating; R Champlin; E Shpall; K Rezvani
Journal:  Leukemia       Date:  2017-07-20       Impact factor: 11.528

8.  Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.

Authors:  A Di Sabatino; R Ciccocioppo; F Cupelli; B Cinque; D Millimaggi; M M Clarkson; M Paulli; M G Cifone; G R Corazza
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

9.  Gab3 is required for IL-2- and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy.

Authors:  Anna Sliz; Kathryn C S Locker; Kristin Lampe; Alzbeta Godarova; David R Plas; Edith M Janssen; Helen Jones; Andrew B Herr; Kasper Hoebe
Journal:  Sci Immunol       Date:  2019-08-02

10.  Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7.

Authors:  G Monteleone; T Parrello; F Luzza; F Pallone
Journal:  Gut       Date:  1998-11       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.